FYN and neoplasm: In pancreatic cancer cell lines, FYN mediates the AKT pathway via phosphorylation of the ionotropic glutamate receptor subunit 2B (GluN2B) at Ser1303, which subsequently phosphorylates AKT, enhancing tumor survival and progression [31, 55].